S. 755: Finn Sawyer Access to Cancer Testing Act
A Senate bill (S.) in the 119th U.S. Congress.
Overview
| Congress | 119th U.S. Congress (2025–2026) |
|---|---|
| Type | Senate bill (S.) |
| Originating chamber | Senate |
| Introduced | 2025-02-26 |
| Sponsor | Sen. Wicker, Roger F. [R-MS] |
| Policy area | Health |
| Cosponsors | 1 |
| Latest action | 2025-02-26 — Read twice and referred to the Committee on Finance. |
| Last updated | 2025-12-05 |
Summary
Official summary (Introduced in Senate, 2025-02-26):
Finn Sawyer Access to Cancer Testing Act
This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.
Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
Cosponsors (1)
| Name | Party / state |
|---|---|
| Amy Klobuchar | D MN (original cosponsor) 2025-02-26 |
Full text & official record
The official bill text, section-by-section summary, amendments, committee reports, and the complete legislative timeline for S. 755 are published by Congress on congress.gov.
Frequently asked questions
What is S. 755?
S. 755 is a Senate bill (S.) introduced in the 119th U.S. Congress, originating in the Senate. Official title: Finn Sawyer Access to Cancer Testing Act.
Where can I read the full bill text?
The full text, cosponsors, amendments, and legislative status for S. 755 are available on congress.gov.
Bill data: congress.gov API (official congressional records).